• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Achievable standards, benchmarks for reporting and criteria for evaluating cervical cytopathology.

作者信息

Herbert A, Johnson J, Patnick J

出版信息

Cytopathology. 1995 Oct;6(5):301-3. doi: 10.1111/j.1365-2303.1995.tb00575.x.

DOI:10.1111/j.1365-2303.1995.tb00575.x
PMID:8785367
Abstract

The cervical smear test, like all screening tests, is not 100% effective in detecting abnormality. In order to prevent 80-90% of invasive cancers, cervical screening requires cervical smears to be taken competently at regular intervals and correctly interpreted. With laboratories following the guidelines in this report, the NHSCSP should be able to meet the Health of the Nation target to reduce the incidence of invasive cervical cancer to less than 12 cases per 100 000 women in the UK by the year 2000.

摘要

相似文献

1
Achievable standards, benchmarks for reporting and criteria for evaluating cervical cytopathology.
Cytopathology. 1995 Oct;6(5):301-3. doi: 10.1111/j.1365-2303.1995.tb00575.x.
2
Achievable standards, benchmarks for reporting and criteria for evaluating cervical cytopathology.
Cytopathology. 1997 Jun;8(3):210. doi: 10.1046/j.1365-2303.1997.d01-640.x.
3
Achievable standards, benchmarks for reporting, and criteria for evaluating cervical cytopathology. Second edition including revised performance indicators.可实现的标准、报告基准以及宫颈细胞病理学评估标准。第二版,包括修订后的绩效指标。
Cytopathology. 2000 Aug;11(4):212-41. doi: 10.1046/j.1365-2303.2000.00269.x.
4
The economics of screening.
Cytopathology. 1997 Jun;8(3):211.
5
Evaluation of the 10% rescreen of negative gynecologic smears as a quality assurance measure.评估将10%的阴性妇科涂片重新筛查作为一种质量保证措施的情况。
Diagn Cytopathol. 1996 Feb;14(1):84-6. doi: 10.1002/(SICI)1097-0339(199602)14:1<84::AID-DC17>3.0.CO;2-9.
6
Present standards for cervical cancer screening.宫颈癌筛查的现行标准。
Curr Opin Oncol. 2002 Sep;14(5):505-11. doi: 10.1097/00001622-200209000-00006.
7
Achievable laboratory standards; a review of cytology of 99 women with cervical cancer.可实现的实验室标准;对99例宫颈癌患者的细胞学检查回顾
Cytopathology. 1998 Jun;9(3):171-7. doi: 10.1046/j.1365-2303.1998.00122.x.
8
Setting standards for cervical screening fail-safe mechanisms: a target based on an audit of cytopathology laboratory records.制定子宫颈筛查故障安全机制的标准:基于细胞病理学实验室记录审核的目标。
J Med Screen. 1995;2(2):102-4. doi: 10.1177/096914139500200210.
9
Cervical screening: what is the point?宫颈癌筛查:意义何在?
Lancet. 1995 Jul 22;346(8969):245; author reply 246-7.
10
The preparation of additional smears from a cervical scrape: impact on the rate of detection of cervical neoplasia.
Cytopathology. 2001 Jun;12(3):151-6. doi: 10.1046/j.1365-2303.2001.00327.x.

引用本文的文献

1
Liquid-Based Cervical Cytology: Monitoring the Laboratory Quality Indicators.液基宫颈细胞学:监测实验室质量指标
J Cytol. 2024 Jan-Mar;41(1):1-7. doi: 10.4103/joc.joc_112_23. Epub 2023 Dec 28.
2
Cervical Cytology-Histology Correlation Based on the American Society of Cytopathology Guideline (2017) at the Russian National Medical Research Center for Obstetrics, Gynecology, and Perinatology.基于美国细胞病理学会指南(2017年)的宫颈细胞学与组织学相关性研究,于俄罗斯国家妇产科与围产医学研究中心开展。
Diagnostics (Basel). 2022 Jan 15;12(1):210. doi: 10.3390/diagnostics12010210.
3
Screening for the prevention and early detection of cervical cancer: protocol for systematic reviews to inform Canadian recommendations.
筛查宫颈癌的预防和早期检测:为加拿大建议提供信息的系统评价方案。
Syst Rev. 2021 Jan 2;10(1):2. doi: 10.1186/s13643-020-01538-9.
4
Technological advances: Have they improved standards? Review of outcomes from the Welsh cervical screening programme.技术进步:它们提高了标准吗?威尔士宫颈筛查计划结果的回顾。
J Med Screen. 2021 Jun;28(2):80-87. doi: 10.1177/0969141320918270. Epub 2020 Apr 16.
5
Information needs of young women vaccinated against HPV attending colposcopy: a qualitative study.接受HPV疫苗接种的年轻女性在接受阴道镜检查时的信息需求:一项定性研究。
BMC Womens Health. 2018 Dec 12;18(1):200. doi: 10.1186/s12905-018-0691-0.
6
Human papillomavirus infection and anxiety: analyses in women with low-grade cervical cytological abnormalities unaware of their infection status.人乳头瘤病毒感染与焦虑:针对低级别宫颈细胞学异常且不知晓自身感染状况的女性的分析。
PLoS One. 2011;6(6):e21046. doi: 10.1371/journal.pone.0021046. Epub 2011 Jun 16.
7
Quality control for normal liquid-based cytology: rescreening, high-risk HPV targeted reviewing and/or high-risk HPV detection?常规液体细胞学的质量控制:重新筛查、高危型 HPV 靶向复查和/或高危型 HPV 检测?
J Cell Mol Med. 2009 Sep;13(9B):4051-60. doi: 10.1111/j.1582-4934.2008.00379.x. Epub 2008 Jun 9.
8
The impact of the introduction of liquid based cytology on the variation in the proportion of inadequate samples between GP practices.采用液基细胞学检查对全科医疗诊所之间不合格样本比例差异的影响。
BMC Public Health. 2007 Aug 1;7:191. doi: 10.1186/1471-2458-7-191.
9
Analysis of inadequate cervical smears using Shewhart control charts.使用休哈特控制图分析宫颈涂片不合格情况。
BMC Public Health. 2004 Jun 29;4:25. doi: 10.1186/1471-2458-4-25.
10
Outcome of women with inadequate cervical smears followed up for five years.宫颈涂片检查结果欠佳的女性随访五年的结果。
J Clin Pathol. 2003 Aug;56(8):592-5. doi: 10.1136/jcp.56.8.592.